Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(18%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
7
64%
Ph phase_3
3
27%
Ph early_phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 3Large-scale testing
3(27.3%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Recruiting1
Active, not recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (9.1%)
Phase 33 (27.3%)
N/A7 (63.6%)

Trials by Status

recruiting19%
active_not_recruiting19%
unknown19%
withdrawn19%
completed764%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11